• A hand of comfort is laid on baby boomer's hand

A hand of comfort is laid on baby boomer's hand (Photo : Getty images/AFP / Stringer)

The computer records every respiration of Prairie Village woman at the University of Kansas Alzheimer's Disease Center. Exercise physiologist asks the patient to push harder to feed carbon dioxide levels to the computer.

"Can you hang in there like for 15 more seconds?", physiologist says to prepare a chart of vitals for exercise combat for people over 50.  Alzheimer's is the second-most-feared disease in the United States, behind cancer.

Like Us on Facebook

Millions of aging Americans similar to Poehler put efforts to escape from the cataclysm of the brain-wasting disease. This disease bothers nearly 5.4 million people. If no cure or prevention is found in the United States this number continues to grow as baby boomers age.

Miami Herald reported, in a national study, published online in the journal JAMA Internal Medicine, positive signs were found that was so far a bleak chance.  The study found that the rate of dementia in people 65 or older has come down from 11.6 percent in 2000 to 8.8 percent in 2012. The researchers are still exploring as reasons for this change are not yet fully understood.

Clinical Alzheimer's is seen in one out of every three people over the age of 85 in the United States and at least one out of 11 are aged over 65.

At the age of 65, Poehler is cognitively healthy and attempts to stay fit. Earlier, Poehler's grandmother suffered due to Alzheimer's and it took away both memory and life, followed by mother who is in a memory care unit.

Baby boomer says that a lot of difficulties is experienced before stepping on the treadmill. Ann Poehler's strides go fast on the treadmill as feet pound and heart races from 150 to 160 beats per minute and more.

 Mohave daily news revealed that a trial treatment for Alzheimer's has failed again. Many were disappointed who hoped drug maker Eli Lilly would finally show a way to slow down the progression of this disease.

The company announced that the drug did not work better than placebo treatment. This result was found in a study of more than 2,100 people affected with mild Alzheimer's.